|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - IDERA PHARMACEUTICALS Inc (IDRA)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2018-12-24 Purchase |
2018-12-26 09:21 am |
IDERA PHARMACEUTICALS Inc | IDRA | MILANO VINCENT CEO |
15,000 | $2.928 | $43,923 | 55,816 (Direct) |
View |
| 2018-12-21 Purchase |
2018-12-26 09:17 am |
IDERA PHARMACEUTICALS Inc | IDRA | Lim Bryant David VP |
4,000 | $3.05 | $12,200 | 4,743 (Direct) |
View |
| 2018-12-20 Purchase |
2018-12-20 5:27 pm |
IDERA PHARMACEUTICALS Inc | IDRA | Horobin Joanna Chief Medical Officer |
300 | $3.45 | $1,035 | 2,044 (Direct) |
View |
| 2018-12-19 Purchase |
2018-12-20 5:26 pm |
IDERA PHARMACEUTICALS Inc | IDRA | Goldberg Mark Alan Director |
10,000 | $3.19 | $31,897 | 10,000 (Direct) |
View |
| 2018-12-18 Purchase |
2018-12-20 5:25 pm |
IDERA PHARMACEUTICALS Inc | IDRA | SCHAFER CAROL Director |
5,000 | $3.334 | $16,671 | 23,000 (Direct) |
View |
| 2018-08-07 Sale |
2018-08-17 5:44 pm |
IDERA PHARMACEUTICALS Inc | IDRA | Pillar Invest Corp Pillar Pharmaceuticals I LP Pillar Pharmaceuticals II L.P. Pillar Pharmaceuticals III L.P. 10% Owner |
300,000 | $5.799 | $1,739,708 | 0 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-07-09 Option Award |
2019-07-11 5:19 pm |
N/A 2029-07-09 |
IDERA PHARMACEUTICALS Inc | IDRA | YINGLING JONATHAN MICHAEL Chief Scientific Officer |
45,500 | $2.52 | 45,500 (Direct) |
View |
| 2019-07-09 Option Award |
2019-07-11 5:18 pm |
N/A 2029-07-09 |
IDERA PHARMACEUTICALS Inc | IDRA | Kirby John J. VP |
45,500 | $2.52 | 45,500 (Direct) |
View |
| 2019-07-09 Option Award |
2019-07-11 5:18 pm |
N/A 2029-07-09 |
IDERA PHARMACEUTICALS Inc | IDRA | Horobin Joanna Chief Medical Officer |
45,500 | $2.52 | 45,500 (Direct) |
View |
| 2019-07-09 Option Award |
2019-07-11 5:18 pm |
N/A 2029-07-09 |
IDERA PHARMACEUTICALS Inc | IDRA | Fletcher Robert C. VP |
45,500 | $2.52 | 45,500 (Direct) |
View |
| 2019-07-09 Option Award |
2019-07-11 5:17 pm |
N/A 2029-07-09 |
IDERA PHARMACEUTICALS Inc | IDRA | Lim Bryant David VP |
45,500 | $2.52 | 45,500 (Direct) |
View |
| 2019-07-09 Option Award |
2019-07-11 5:13 pm |
N/A 2029-07-09 |
IDERA PHARMACEUTICALS Inc | IDRA | MILANO VINCENT CEO |
84,500 | $2.52 | 84,500 (Direct) |
View |
| 2019-07-01 Option Award |
2019-07-03 1:15 pm |
N/A N/A |
IDERA PHARMACEUTICALS Inc | IDRA | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC BAKER FELIX BAKER JULIAN 10% Owner |
2,964 | $2.61 | 4,290,995 (Indirect) |
View |
| 2019-07-01 Option Award |
2019-07-03 1:15 pm |
N/A N/A |
IDERA PHARMACEUTICALS Inc | IDRA | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC BAKER FELIX BAKER JULIAN 10% Owner |
2,964 | $2.61 | 4,290,995 (Indirect) |
View |
| 2019-07-01 Option Award |
2019-07-02 4:39 pm |
N/A N/A |
IDERA PHARMACEUTICALS Inc | IDRA | PIEN HOWARD H Director |
4,469 | $2.61 | 11,790 (Direct) |
View |
| 2019-07-01 Option Award |
2019-07-02 4:38 pm |
N/A N/A |
IDERA PHARMACEUTICALS Inc | IDRA | SCHAFER CAROL Director |
5,179 | $2.61 | 15,345 (Direct) |
View |
| 2019-06-06 Other |
2019-06-07 6:29 pm |
N/A N/A |
IDERA PHARMACEUTICALS Inc | IDRA | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC BAKER FELIX BAKER JULIAN 10% Owner |
178,967 | $0 | 4,288,031 (Indirect) |
View |
| 2019-06-06 Other |
2019-06-07 6:29 pm |
N/A N/A |
IDERA PHARMACEUTICALS Inc | IDRA | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC BAKER FELIX BAKER JULIAN 10% Owner |
59,267 | $0 | 4,288,031 (Indirect) |
View |
| 2019-06-06 Other |
2019-06-07 6:29 pm |
N/A N/A |
IDERA PHARMACEUTICALS Inc | IDRA | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC BAKER FELIX BAKER JULIAN 10% Owner |
21,929 | $0 | 4,288,031 (Direct) |
View |
| 2019-06-06 Other |
2019-06-07 6:29 pm |
N/A N/A |
IDERA PHARMACEUTICALS Inc | IDRA | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC BAKER FELIX BAKER JULIAN 10% Owner |
21,929 | $0 | 4,288,031 (Direct) |
View |
| 2019-06-06 Other |
2019-06-07 6:29 pm |
2013-05-07 2020-05-07 |
IDERA PHARMACEUTICALS Inc | IDRA | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC BAKER FELIX BAKER JULIAN 10% Owner |
42,724 | $0.08 | 4,288,031 (Indirect) |
View |
| 2019-06-06 Other |
2019-06-07 6:29 pm |
2013-09-25 2020-09-30 |
IDERA PHARMACEUTICALS Inc | IDRA | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC BAKER FELIX BAKER JULIAN 10% Owner |
11,337 | $0.08 | 4,288,031 (Indirect) |
View |
| 2019-06-06 Other |
2019-06-07 6:29 pm |
2014-02-05 2021-02-10 |
IDERA PHARMACEUTICALS Inc | IDRA | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC BAKER FELIX BAKER JULIAN 10% Owner |
6,009 | $0.08 | 4,288,031 (Indirect) |
View |
| 2019-06-06 Other |
2019-06-07 6:29 pm |
2013-05-07 2020-05-07 |
IDERA PHARMACEUTICALS Inc | IDRA | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC BAKER FELIX BAKER JULIAN 10% Owner |
6,256 | $0.08 | 4,288,031 (Direct) |
View |
| 2019-06-06 Other |
2019-06-07 6:29 pm |
2013-09-25 2020-09-30 |
IDERA PHARMACEUTICALS Inc | IDRA | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC BAKER FELIX BAKER JULIAN 10% Owner |
1,660 | $0.08 | 4,288,031 (Direct) |
View |
| 2019-06-06 Other |
2019-06-07 6:29 pm |
2014-02-05 2021-02-10 |
IDERA PHARMACEUTICALS Inc | IDRA | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC BAKER FELIX BAKER JULIAN 10% Owner |
880 | $0.08 | 4,288,031 (Direct) |
View |
| 2019-06-06 Other |
2019-06-07 6:29 pm |
2013-05-07 2020-05-07 |
IDERA PHARMACEUTICALS Inc | IDRA | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC BAKER FELIX BAKER JULIAN 10% Owner |
6,256 | $0.08 | 4,288,031 (Direct) |
View |
| 2019-06-06 Other |
2019-06-07 6:29 pm |
2013-09-25 2020-09-30 |
IDERA PHARMACEUTICALS Inc | IDRA | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC BAKER FELIX BAKER JULIAN 10% Owner |
1,660 | $0.08 | 4,288,031 (Direct) |
View |
| 2019-06-06 Other |
2019-06-07 6:29 pm |
2014-02-05 2021-02-10 |
IDERA PHARMACEUTICALS Inc | IDRA | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC BAKER FELIX BAKER JULIAN 10% Owner |
880 | $0.08 | 4,288,031 (Direct) |
View |
| 2019-06-04 Option Award |
2019-06-06 4:08 pm |
2020-06-04 2029-06-04 |
IDERA PHARMACEUTICALS Inc | IDRA | GERAGHTY JAMES A Director |
14,500 | $2.57 | 14,500 (Direct) |
View |
| 2019-06-04 Option Award |
2019-06-06 4:07 pm |
2020-06-04 2029-06-04 |
IDERA PHARMACEUTICALS Inc | IDRA | SCHAFER CAROL Director |
11,500 | $2.57 | 11,500 (Direct) |
View |
| 2019-06-04 Option Award |
2019-06-06 4:06 pm |
2020-06-04 2029-06-04 |
IDERA PHARMACEUTICALS Inc | IDRA | PIEN HOWARD H Director |
11,500 | $2.57 | 11,500 (Direct) |
View |
| 2019-06-04 Option Award |
2019-06-06 4:06 pm |
2020-06-04 2029-06-04 |
IDERA PHARMACEUTICALS Inc | IDRA | GOWEN MAXINE Director |
11,500 | $2.57 | 11,500 (Direct) |
View |
| 2019-06-04 Option Award |
2019-06-06 4:05 pm |
2020-06-04 2029-06-04 |
IDERA PHARMACEUTICALS Inc | IDRA | Goldberg Mark Alan Director |
11,500 | $2.57 | 11,500 (Direct) |
View |
| 2019-06-04 Option Award |
2019-06-06 4:04 pm |
2020-06-04 2029-06-04 |
IDERA PHARMACEUTICALS Inc | IDRA | DOUGHERTY MICHAEL R Director |
11,500 | $2.57 | 11,500 (Direct) |
View |
| 2019-06-04 Option Award |
2019-06-06 4:03 pm |
2020-06-04 2029-06-04 |
IDERA PHARMACEUTICALS Inc | IDRA | Csimma Cristina Director |
11,500 | $2.57 | 11,500 (Direct) |
View |
| 2019-04-08 Option Award |
2019-04-10 5:38 pm |
N/A 2029-04-08 |
IDERA PHARMACEUTICALS Inc | IDRA | DOUGHERTY MICHAEL R Director |
23,000 | $2.66 | 23,000 (Direct) |
View |
| 2019-04-08 Option Award |
2019-04-10 5:36 pm |
N/A 2029-04-08 |
IDERA PHARMACEUTICALS Inc | IDRA | Csimma Cristina Director |
23,000 | $2.66 | 23,000 (Direct) |
View |
| 2019-04-01 Option Award |
2019-04-03 5:36 pm |
N/A N/A |
IDERA PHARMACEUTICALS Inc | IDRA | BAKER BROS. ADVISORS LP 14159 L.P. 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director, 10% Owner |
4,161 | $2.59 | 4,288,031 (Indirect) |
View |
| 2019-04-01 Option Award |
2019-04-03 5:36 pm |
N/A N/A |
IDERA PHARMACEUTICALS Inc | IDRA | BAKER BROS. ADVISORS LP 14159 L.P. 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director, 10% Owner |
4,161 | $2.59 | 4,288,031 (Indirect) |
View |
| 2019-04-01 Option Award |
2019-04-03 5:36 pm |
N/A N/A |
IDERA PHARMACEUTICALS Inc | IDRA | BAKER BROS. ADVISORS LP 14159 L.P. 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director, 10% Owner |
4,161 | $2.59 | 4,288,031 (Indirect) |
View |
| 2019-04-01 Option Award |
2019-04-02 5:17 pm |
N/A N/A |
IDERA PHARMACEUTICALS Inc | IDRA | PIEN HOWARD H Director |
4,392 | $2.59 | 7,321 (Direct) |
View |
| 2019-04-01 Option Award |
2019-04-02 5:17 pm |
N/A N/A |
IDERA PHARMACEUTICALS Inc | IDRA | SCHAFER CAROL Director |
5,166 | $2.59 | 10,166 (Direct) |
View |
| 2019-01-03 Option Award |
2019-01-07 8:29 pm |
N/A N/A |
IDERA PHARMACEUTICALS Inc | IDRA | YINGLING JONATHAN MICHAEL Chief Scientific Officer |
18,100 | $0 | 45,500 (Direct) |
View |
| 2019-01-03 Option Award |
2019-01-07 8:29 pm |
N/A 2029-01-03 |
IDERA PHARMACEUTICALS Inc | IDRA | YINGLING JONATHAN MICHAEL Chief Scientific Officer |
45,500 | $3.14 | 45,500 (Direct) |
View |
| 2019-01-03 Option Award |
2019-01-07 8:24 pm |
N/A N/A |
IDERA PHARMACEUTICALS Inc | IDRA | Horobin Joanna Chief Medical Officer |
18,100 | $0 | 45,500 (Direct) |
View |
| 2019-01-03 Option Award |
2019-01-07 8:24 pm |
N/A 2029-01-03 |
IDERA PHARMACEUTICALS Inc | IDRA | Horobin Joanna Chief Medical Officer |
45,500 | $3.14 | 45,500 (Direct) |
View |
| 2019-01-03 Option Award |
2019-01-07 8:22 pm |
N/A N/A |
IDERA PHARMACEUTICALS Inc | IDRA | Fletcher Robert C. VP |
18,100 | $0 | 45,500 (Direct) |
View |
| 2019-01-03 Option Award |
2019-01-07 8:22 pm |
N/A 2029-01-03 |
IDERA PHARMACEUTICALS Inc | IDRA | Fletcher Robert C. VP |
45,500 | $3.14 | 45,500 (Direct) |
View |
| 2019-01-03 Option Award |
2019-01-07 8:17 pm |
N/A N/A |
IDERA PHARMACEUTICALS Inc | IDRA | Kirby John J. VP |
10,250 | $0 | 25,600 (Direct) |
View |
| 2019-01-03 Option Award |
2019-01-07 8:17 pm |
N/A 2029-01-03 |
IDERA PHARMACEUTICALS Inc | IDRA | Kirby John J. VP |
25,600 | $3.14 | 25,600 (Direct) |
View |
| 2019-01-03 Option Award |
2019-01-07 8:14 pm |
N/A N/A |
IDERA PHARMACEUTICALS Inc | IDRA | Lim Bryant David VP |
18,100 | $0 | 45,500 (Direct) |
View |
| 2019-01-03 Option Award |
2019-01-07 8:14 pm |
N/A 2029-01-03 |
IDERA PHARMACEUTICALS Inc | IDRA | Lim Bryant David VP |
45,500 | $3.14 | 45,500 (Direct) |
View |
| 2019-01-03 Option Award |
2019-01-07 8:11 pm |
N/A N/A |
IDERA PHARMACEUTICALS Inc | IDRA | MILANO VINCENT CEO |
33,750 | $0 | 89,566 (Direct) |
View |
| 2019-01-03 Option Award |
2019-01-07 8:11 pm |
N/A 2029-01-03 |
IDERA PHARMACEUTICALS Inc | IDRA | MILANO VINCENT CEO |
84,500 | $3.14 | 89,566 (Direct) |
View |
| 2019-01-02 Option Award |
2019-01-04 4:52 pm |
N/A N/A |
IDERA PHARMACEUTICALS Inc | IDRA | BAKER BROS. ADVISORS LP 14159 L.P. 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director, 10% Owner |
3,658 | $3.52 | 4,283,870 (Indirect) |
View |
| 2019-01-02 Option Award |
2019-01-04 4:52 pm |
N/A N/A |
IDERA PHARMACEUTICALS Inc | IDRA | BAKER BROS. ADVISORS LP 14159 L.P. 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director, 10% Owner |
3,658 | $3.52 | 4,283,870 (Indirect) |
View |
| 2019-01-02 Option Award |
2019-01-04 4:52 pm |
N/A N/A |
IDERA PHARMACEUTICALS Inc | IDRA | BAKER BROS. ADVISORS LP 14159 L.P. 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director, 10% Owner |
3,658 | $3.52 | 4,283,870 (Indirect) |
View |
| 2019-01-02 Option Award |
2019-01-03 4:41 pm |
N/A N/A |
IDERA PHARMACEUTICALS Inc | IDRA | PIEN HOWARD H Director |
2,929 | $3.52 | 2,929 (Direct) |
View |
| 2018-12-18 Option Award |
2018-12-20 5:25 pm |
N/A 2028-12-18 |
IDERA PHARMACEUTICALS Inc | IDRA | SCHAFER CAROL Director |
23,000 | $3.12 | 23,000 (Direct) |
View |
| 2018-10-01 Option Award |
2018-10-03 8:37 pm |
N/A N/A |
IDERA PHARMACEUTICALS Inc | IDRA | BAKER BROS. ADVISORS LP 14159 L.P. 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director, 10% Owner |
2,340 | $8.71 | 4,280,212 (Indirect) |
View |
| 2018-10-01 Option Award |
2018-10-03 8:37 pm |
N/A N/A |
IDERA PHARMACEUTICALS Inc | IDRA | BAKER BROS. ADVISORS LP 14159 L.P. 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director, 10% Owner |
2,340 | $8.71 | 4,280,212 (Indirect) |
View |
| 2018-10-01 Option Award |
2018-10-03 8:37 pm |
N/A N/A |
IDERA PHARMACEUTICALS Inc | IDRA | BAKER BROS. ADVISORS LP 14159 L.P. 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director, 10% Owner |
2,340 | $8.71 | 4,280,212 (Indirect) |
View |
| 2018-09-18 Option Award |
2018-09-20 5:06 pm |
N/A 2028-09-18 |
IDERA PHARMACEUTICALS Inc | IDRA | PIEN HOWARD H Director |
23,000 | $7.99 | 23,000 (Direct) |
View |
| 2018-09-10 Option Award |
2018-09-13 4:20 pm |
N/A 2028-09-10 |
IDERA PHARMACEUTICALS Inc | IDRA | Lim Bryant David VP |
130,000 | $9.29 | 130,000 (Direct) |
View |
| 2018-08-13 Option Award |
2018-08-15 4:32 pm |
N/A 2028-08-13 |
IDERA PHARMACEUTICALS Inc | IDRA | MILANO VINCENT CEO |
65,000 | $7.39 | 65,000 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Wed, 17 Jul 2019 17:44:05 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |